A generalisability theory approach to quantifying changes in psychopathology among ultra-high-risk individuals for psychosis

被引:0
|
作者
Doborjeh, Zohreh [1 ,2 ]
Medvedev, Oleg N. [3 ]
Doborjeh, Maryam [1 ]
Singh, Balkaran [1 ]
Sumich, Alexander [4 ,5 ]
Budhraja, Sugam [1 ]
Goh, Wilson Wen Bin [6 ,7 ,8 ,9 ,10 ]
Lee, Jimmy [6 ,11 ]
Williams, Margaret [12 ]
Lai, Edmund M-k [1 ,13 ]
Kasabov, Nikola [1 ,13 ,14 ]
机构
[1] Auckland Univ Technol, Sch Engn Comp & Math Sci, Knowledge Engn & Discovery Res Inst, Auckland, New Zealand
[2] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland, New Zealand
[3] Univ Waikato, Sch Psychol & Social Sci, Hamilton, New Zealand
[4] Nottingham Trent Univ, Sch Social Sci, NTU Psychol, Nottingham, England
[5] Auckland Univ Technol, Dept Psychol & Neurosci, Auckland, New Zealand
[6] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[7] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore
[8] Nanyang Technol Univ, Ctr Biomed Informat, Singapore, Singapore
[9] Nanyang Technol Univ, Ctr AI Med, Singapore, Singapore
[10] Imperial Coll London, Fac Med, Dept Brain Sci, Div Neurol, London, England
[11] Inst Mental Hlth, Singapore, Singapore
[12] Auckland Univ Technol, Sch Publ Hlth & Interdisciplinary Studies, Auckland, New Zealand
[13] Dalian Univ, Sch Software Engn, Dalian, Peoples R China
[14] Bulgarian Acad Sci, Inst Informat & Commun Technol, Sofia, Bulgaria
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
NEGATIVE-SYNDROME-SCALE; 5-FACTOR MODEL; SCHIZOPHRENIA; SYMPTOMS; PANSS; METAANALYSIS; COGNITION; GUIDE; TIME;
D O I
10.1038/s41537-024-00503-y
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Distinguishing stable and fluctuating psychopathological features in young individuals at Ultra High Risk (UHR) for psychosis is challenging, but critical for building robust, accurate, early clinical detection and prevention capabilities. Over a 24-month period, 159 UHR individuals were assessed using the Positive and Negative Symptom Scale (PANSS). Generalisability Theory was used to validate the PANSS with this population and to investigate stable and fluctuating features, by estimating the reliability and generalisability of three factor (Positive, Negative, and General) and five factor (Positive, Negative, Cognitive, Depression, and Hostility) symptom models. Acceptable reliability and generalisability of scores across occasions and sample population were demonstrated by the total PANSS scale (Gr = 0.85). Fluctuating symptoms (delusions, hallucinatory behaviour, lack of spontaneity, flow in conversation, emotional withdrawal, and somatic concern) showed high variability over time, with 50-68% of the variance explained by individual transient states. In contrast, more stable symptoms included excitement, poor rapport, anxiety, guilt feeling, uncooperativeness, and poor impulse control. The 3-factor model of PANSS and its subscales showed robust reliability and generalisability of their assessment scores across the UHR population and evaluation periods (G = 0.77-0.93), offering a suitable means to assess psychosis risk. Certain subscales within the 5-factor PANSS model showed comparatively lower reliability and generalisability (G = 0.33-0.66). The identified and investigated fluctuating symptoms in UHR individuals are more amendable by means of intervention, which could have significant implications for preventing and addressing psychosis. Prioritising the treatment of fluctuating symptoms could enhance intervention efficacy, offering a sharper focus in clinical trials. At the same time, using more reliable total scale and 3 subscales can contribute to more accurate assessment of enduring psychosis patterns in clinical and experimental settings.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] White-matter markers for psychosis in a prospective ultra-high-risk cohort
    Bloemen, O. J. N.
    de Koning, M. B.
    Schmitz, N.
    Nieman, D. H.
    Becker, H. E.
    de Haan, L.
    Dingemans, P.
    Linszen, D. H.
    van Amelsvoort, T. A. M. J.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (08) : 1297 - 1304
  • [32] Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis
    Jhon, Min
    Amminger, Paul
    Berk, Michael
    Kim, Jae-Min
    Kim, Sung-Wan
    Klier, Claudia M.
    Rice, Simon
    Schaefer, Miriam R.
    Smesny, Stefan
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 225 - 225
  • [33] Membrane Lipids in Ultra-High-Risk Patients: Potential Predictive Biomarkers of Conversion to Psychosis
    Frajerman, Ariel
    Chaumette, Boris
    Farabos, Dominique
    Despres, Gaetan
    Simonard, Christelle
    Lamaziere, Antonin
    Krebs, Marie-Odile
    Kebir, Oussama
    NUTRIENTS, 2023, 15 (09)
  • [34] No individual prediction of clinical outcome of ultra-high-risk individuals by the polygenic risk scores
    He, Q.
    Kebir, O.
    Houle, G.
    Dion, P. A.
    Rouleau, G. A.
    Krebs, M.
    Chaumette, B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1456 - 1457
  • [35] Bullying in individuals at ultra-high risk for psychosis
    Fekih-Romdhane, Feten
    Cheour, Majda
    ANNALES MEDICO-PSYCHOLOGIQUES, 2023, 181 (04): : 325 - 329
  • [36] Symptom Dimensions in Individuals at Ultra High Risk for Psychosis
    Azis, Matilda
    Allen, Paul
    Modinos, Gemma
    Bonoldi, Ilaria
    Bossong, Matthijs
    Samson, Carly
    Quinn, Beverly
    McGuire, Phillip
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 : 116 - 116
  • [37] Investigation of social and cognitive predictors in non-transition ultra-high-risk' individuals for psychosis using spiking neural networks
    Doborjeh, Zohreh
    Doborjeh, Maryam
    Sumich, Alexander
    Singh, Balkaran
    Merkin, Alexander
    Budhraja, Sugam
    Goh, Wilson
    Lai, Edmund M-K
    Williams, Margaret
    Tan, Samuel
    Lee, Jimmy
    Kasabov, Nikola
    SCHIZOPHRENIA, 2023, 9 (01)
  • [38] Dissociate symptoms in adolescents referred to a ultra-high-risk for psychosis early intervention programme
    Gago, E.
    Minano, M.
    Perez, S.
    Serra, P.
    Pamias Massana, M.
    Palao Vidal, D.
    Labad, J.
    EUROPEAN PSYCHIATRY, 2020, 63 : S79 - S79
  • [39] SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) IN PATIENTS AT ULTRA-HIGH-RISK FOR PSYCHOSIS
    Loewy, Rachel L.
    Fisher, M.
    Stuart, B.
    Holland, C.
    Mellon, S.
    Wolkowitz, O.
    Vinogradov, S.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 257 - 257
  • [40] Evidence that treatment prevents transition to psychosis in ultra-high-risk patients remains questionable
    Amos, Andrew James
    SCHIZOPHRENIA RESEARCH, 2014, 153 (1-3) : 240 - 240